Stephen J. Zoog

1.0k total citations
31 papers, 725 citations indexed

About

Stephen J. Zoog is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Stephen J. Zoog has authored 31 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Genetics and 10 papers in Oncology. Recurrent topics in Stephen J. Zoog's work include Virus-based gene therapy research (11 papers), CAR-T cell therapy research (9 papers) and Cell death mechanisms and regulation (5 papers). Stephen J. Zoog is often cited by papers focused on Virus-based gene therapy research (11 papers), CAR-T cell therapy research (9 papers) and Cell death mechanisms and regulation (5 papers). Stephen J. Zoog collaborates with scholars based in United States, United Kingdom and Israel. Stephen J. Zoog's co-authors include Christian Vettermann, Paul D. Friesen, Brian Long, Jennifer Schiller, Justin Wetter, Nor Chejanovsky, Becky Schweighardt, Laurie Tsuruda, Matthew Peach and Marilyn R. Kehry and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The EMBO Journal.

In The Last Decade

Stephen J. Zoog

30 papers receiving 698 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen J. Zoog United States	15	439	253	234	136	76	31	725
Anna Karin Nilsson Sweden	15	508 1.2×	131 0.5×	72 0.3×	149 1.1×	30 0.4×	28	840
Natsuki Sasaki Japan	10	382 0.9×	171 0.7×	74 0.3×	171 1.3×	54 0.7×	17	677
Dan A. Wiginton United States	24	1.0k 2.4×	657 2.6×	225 1.0×	245 1.8×	73 1.0×	41	1.5k
A D Moulton United States	9	846 1.9×	416 1.6×	172 0.7×	113 0.8×	47 0.6×	11	1.1k
Hui Cao China	17	1.4k 3.3×	158 0.6×	66 0.3×	105 0.8×	88 1.2×	44	1.7k
Amy Goodale United States	9	664 1.5×	68 0.3×	159 0.7×	80 0.6×	33 0.4×	16	861
Sébastien Soubeyrand Canada	18	520 1.2×	112 0.4×	152 0.6×	89 0.7×	11 0.1×	37	832
Raffaele Fronza Germany	14	689 1.6×	382 1.5×	180 0.8×	116 0.9×	35 0.5×	30	980
Jay S. Lillquist United States	15	499 1.1×	131 0.5×	160 0.7×	157 1.2×	18 0.2×	23	857
Dianne C. Skelton United States	16	637 1.5×	547 2.2×	298 1.3×	269 2.0×	59 0.8×	23	1.1k

Countries citing papers authored by Stephen J. Zoog

Since Specialization

Citations

This map shows the geographic impact of Stephen J. Zoog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen J. Zoog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen J. Zoog more than expected).

Fields of papers citing papers by Stephen J. Zoog

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen J. Zoog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen J. Zoog. The network helps show where Stephen J. Zoog may publish in the future.

Co-authorship network of co-authors of Stephen J. Zoog

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen J. Zoog. A scholar is included among the top collaborators of Stephen J. Zoog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen J. Zoog. Stephen J. Zoog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Bowen, Alisa, Jennifer Holcomb, Tara M. Robinson, et al.. (2024). Blood biodistribution and vector shedding of valoctocogene roxaparvovec in people with severe hemophilia A. Blood Advances. 8(17). 4606–4615. 2 indexed citations

2.

Yang, Fan, Jennifer Holcomb, Kathryn Patton, et al.. (2021). Ultra-sensitive AAV capsid detection by immunocapture-based qPCR following factor VIII gene transfer. Gene Therapy. 29(1-2). 94–105. 3 indexed citations

3.

Rosén, S., Stefan Tiefenbacher, Mary Robinson, et al.. (2020). Activity of transgene-produced B-domain–deleted factor VIII in human plasma following AAV5 gene therapy. Blood. 136(22). 2524–2534. 49 indexed citations

4.

Long, Brian, P. Véron, Klaudia Kuranda, et al.. (2020). Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A. Molecular Therapy. 29(2). 597–610. 54 indexed citations

5.

Larimore, Kevin, Roberto Zori, Gillian Shepherd, et al.. (2019). Depletion of interfering IgG and IgM is critical to determine the role of IgE in pegvaliase-associated hypersensitivity. Journal of Immunological Methods. 468. 20–28. 7 indexed citations

6.

Long, Brian, Jennifer Holcomb, Gregory M. Hayes, et al.. (2019). The Impact of Pre-existing Immunity on the Non-clinical Pharmacodynamics of AAV5-Based Gene Therapy. Molecular Therapy — Methods & Clinical Development. 13. 440–452. 55 indexed citations

7.

deHart, Gregory W., et al.. (2018). Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay. Journal of Visualized Experiments. 1 indexed citations

8.

Gupta, Soumi, Cary O. Harding, Gillian Shepherd, et al.. (2018). Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials. EBioMedicine. 37. 366–373. 59 indexed citations

9.

deHart, Gregory W., et al.. (2018). Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay. Journal of Visualized Experiments. 3 indexed citations

10.

Long, Brian, Jennifer Holcomb, Charles O’Neill, et al.. (2017). Impact of Pre-Existing Immunogenicity to AAV on Vector Transduction By Bmn 270, an AAV5-Based Gene Therapy Treatment for Hemophilia A. Blood. 130. 3332–3332. 2 indexed citations

11.

Yates, Bridget, Brian Long, Laurie Tsuruda, et al.. (2017). Strategy to detect pre-existing immunity to AAV gene therapy. Gene Therapy. 24(12). 768–778. 79 indexed citations

12.

Melton, Andrew C., Troy Tompkins, Brian Long, et al.. (2016). Antibodies that neutralize cellular uptake of elosulfase alfa are not associated with reduced efficacy or pharmacodynamic effect in individuals with Morquio A syndrome. Journal of Immunological Methods. 440. 41–51. 14 indexed citations

13.

Peng, Jeffrey, Jill A. Dalton, Mark T. Butt, et al.. (2016). Reveglucosidase alfa (BMN 701), an IGF2-Tagged rhAcid α-Glucosidase, Improves Respiratory Functional Parameters in a Murine Model of Pompe Disease. Journal of Pharmacology and Experimental Therapeutics. 360(2). 313–323. 9 indexed citations

14.

Juan, Gloria, Tammy L. Bush, Raffi Manoukian, et al.. (2014). AMG 900, a potent inhibitor of aurora kinases causes pharmacodynamic changes in p-Histone H3 immunoreactivity in human tumor xenografts and proliferating mouse tissues. Journal of Translational Medicine. 12(1). 307–307. 10 indexed citations

15.

Juan, Gloria, Stephen J. Zoog, & John Ferbas. (2011). Leveraging Image Cytometry for the Development of Clinically Feasible Biomarkers: Evaluation of Activated Caspase-3 in Fine Needle Aspirate Biopsies. Methods in cell biology. 102. 309–320. 1 indexed citations

16.

Kaplan‐Lefko, Paula, Jonathan D. Graves, Stephen J. Zoog, et al.. (2010). Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor types. Cancer Biology & Therapy. 9(8). 618–631. 100 indexed citations

17.

Zoog, Stephen J., Andrea Itano, Esther S. Trueblood, et al.. (2008). Antagonists of CD117 (cKit) signaling inhibit mast cell accumulation in healing skin wounds. Cytometry Part A. 75A(3). 189–198. 11 indexed citations

18.

Zoog, Stephen J., Vladimir V. Papov, Steven S. Pullen, Scott Jakes, & Marilyn R. Kehry. (2003). Signaling and protein associations of a cell permeable CD40 complex in B cells. Molecular Immunology. 40(10). 681–694. 4 indexed citations

19.

Zoog, Stephen J., Jennifer Schiller, Justin Wetter, Nor Chejanovsky, & Paul D. Friesen. (2002). Baculovirus apoptotic suppressor P49 is a substrate inhibitor of initiator caspases resistant to P35 in vivo. The EMBO Journal. 21(19). 5130–5140. 78 indexed citations

20.

Werneburg, Brian, Stephen J. Zoog, Thu Thi Dang, Marilyn R. Kehry, & James J. Crute. (2001). Molecular Characterization of CD40 Signaling Intermediates. Journal of Biological Chemistry. 276(46). 43334–43342. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact